Hua Sun

PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction[S]

Jeffrey T. Chang, R. Krauss, B. Teng, 2017, Journal of Lipid Research.

Non-Native Conformational Isomers of the Catalytic Domain of PCSK9 Induce an Immune Response, Reduce Lipids and Increase LDL Receptor Levels

Jui-Yoa Chang, Li Li, B. Teng, 2018, International journal of molecular sciences.

Proprotein Convertase Subtilisin/Kexin Type 9 Interacts With Apolipoprotein B and Prevents Its Intracellular Degradation, Irrespective of the Low-Density Lipoprotein Receptor

M. Xiong, Z. Yao, Ningyan Zhang, 2012, Arteriosclerosis, thrombosis, and vascular biology.

The role of insulin and incretin-based drugs in biliary tract cancer: epidemiological and experimental evidence

Hua Sun, Xiaohui Qi, 2022, Discover Oncology.

Differential expression of genes in the calcium-signaling pathway underlies lesion development in the LDb mouse model of atherosclerosis.

Lei Zhao, L. Shimmin, J. Hixson, 2010, Atherosclerosis.

THE NEW ROLE OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9: A CONNECTION OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, APOLIPOPROTEIN B, and AUTOPHAGY

Hua Sun, 2012 .

Long-term Expression of Apolipoprotein B mRNA-specific Hammerhead Ribozyme via scAAV8.2 Vector Inhibits Atherosclerosis in Mice

D. Ford, B. Teng, Ying Cao, 2013, Molecular therapy. Nucleic acids.

Epac1 (Exchange Protein Directly Activated by cAMP 1) Upregulates LOX-1 (Oxidized Low-Density Lipoprotein Receptor 1) to Promote Foam Cell Formation and Atherosclerosis Development

D. Milewicz, Xiaodong Cheng, B. Teng, 2020, Arteriosclerosis, thrombosis, and vascular biology.